Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Angiotensinogen and plasminogen activator inhibitor-1 gene polymorphism in relation to chronic allograft dysfunction.

Clinical transplantation - 1 Feb 2005

Reis Kadriye, Arinsoy Turgay, Derici Ulver, Gonen Sevim, Bicik Zerrin, Soylemezoglu Oguz, Yasavul Unal, Hasanoglu Enver, Sindel Sukru

Abstract excerpt

Chronic allograft dysfunction (CAD) is the most common cause of allograft failure in the long-term, and current immunologic strategies have little effect on this condition. The renin-angiotensin system (RAS) plays important roles progression of chronic renal disease. It is thought that plasminogen activator inhibitor-1 (PAI-1) functions in the RAS, in addition to involvement in thrombotic risk and fibrosis. This...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Angiotensinogen
Share to AGT gene

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Predisposition to Disease

Share to Kidney Failure, Chronic

Share to Kidney Transplantation

Share to Plasminogen Activator Inhibitor 1

Share to Polymorphism, Genetic

Share to Renin-Angiotensin System

Source

Identifiers

PMID: 15659127
DOI: 10.1111/j.1399-0012.2004.00187.x

Genes

CAD
AGT

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Angiotensinogen and plasminogen activator inhibitor-1 gene polymorphism in relation to chronic allograft dysfunction.PMID 15659127Read ↗

Angiotensinogen, angiotensine converting enzyme and plasminogen activator inhibitor-1 gene polymorphism in chronic allograft dysfunction.Semantic proximity Read ↗

Gene polymorphisms in renal transplantation.Semantic proximity Read ↗

Genetic polymorphisms located in TGFB1, AGTR1, and VEGFA genes are associated to chronic renal allograft dysfunction.Semantic proximity Read ↗

Plasminogen activator inhibitor-1 polymorphism is associated with progressive renal dysfunction after acute rejection in renal transplant recipients.Semantic proximity Read ↗

Role of genetic variants of the renin-angiotensin system in chronic renal allograft injury.Semantic proximity Read ↗

Genetic predisposition and renal allograft failure: implication of non-HLA genetic variants.Semantic proximity Read ↗

Chronic graft dysfunction in renal transplant patients: potential role of plasminogen activator inhibitor type 1.Semantic proximity Read ↗

The effect of angiotensin converting enzyme gene polymorphism on chronic allograft dysfunction in living donor renal transplant recipients.Semantic proximity Read ↗

Association of the genetic polymorphisms of the renin-angiotensin system and endothelial nitric oxide synthase with chronic renal transplant dysfunction.Semantic proximity Read ↗

Angiotensin converting enzyme gene polymorphism in renal transplant patients with IgA nephropathy: relationship with graft function and prevalence of hypertension.Semantic proximity Read ↗

Angiotensinogen M235T genotype predicts progression in chronic renal allograft dysfunction.Semantic proximity Read ↗

New insights into the renin-angiotensin system and hypertensive renal disease.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.